• Search
  • Basket
    You have no items in your basket
 

Toolbox

Grants and Collaborations-contributions from third parties

Hosted by ZonMw, this page provides guidance on how to set these agreements out properly and what to look out for. This information is intended as an aid in establishing (collaboration) agreements; no rights can be derived from this.

 

Impact

Tea with ASTP: WIPO Mediation and Tech Transfer Disputes

This Webinar focused on the conduct of mediation, including the online conduct of mediation, with a particular reference to the practical case application of the WIPO Mediation Rules in international IP and technology disputes.

  • Aimed at: Academic leaders at research centres, TTO & KTO Directors
 

Impact

EPO in the TT Landscape

This webinar cast a light on EPO's technology transfer initiatives and its future plans. The role played by the cooperation with organisations such as ASTP in this context is essential.

  • Aimed at: Academic leaders at research centres, TTO & KTO Directors
 

Toolbox

Doing Business in the United States

Biotechnology and genetics research have been the subject of extensive investment by both the public and private sectors, with the resulting products and processes making a significant and increasing contribution to human health and health care.

 

Impact

Tea with ASTP: Defining Inventorship

We have all been involved in cases regarding inventorship. Some of these situations can be either tricky or can be solved in a more fact-based manner. Research staff often don't know the difference between a co-author of an article and a co-inventor. This webinar drills down into the details of Defining Inventorship.

  • Aimed at: Academic leaders at research centres, TTO & KTO Directors
 

Impact

Tea with ASTP: The Researcher's Perspective on KT

Are we also listening to the researchers? Do we really know what they think about our way of working? How do they perceive the information they get from us? Both presenters have been involved in knowledge transfer and commercialisation who share their views and impressions of the knowledge transfer process with us.

  • Aimed at: Academic leaders at research centres, TTO & KTO Directors
 

Impact

Tea with ASTP: Dealing with new plant varieties

The development of new and improved varieties of plants benefits the economy by increasing the marketability of crops and improving rural income and overall economic development.

  • Aimed at: Academic leaders at research centres, TTO & KTO Directors
 

Impact

Study highlights economic benefits of owning IP rights

Released by the EPO and the EUIPO, this study shows that companies which own at least one patent, registered design or trade mark generate on average 20% higher revenues per employee than companies which do not own any of those intellectual property rights (IPRs).

  • Aimed at: Academic leaders at research centres, TTO & KTO Directors , SMEs
  • University: EPO report
 

Impact

Tea with ASTP: Policies for Spin-out

Most KTOs work with the spin-out route as a way of commercialising inventions from our research institutions: there are different models and policies in place at different KTOs. Marjan Kraak (Head of Spin-Off Group, ETH Transfer at ETH Zurich) take us through ETH Zurich's models and processes.

  • Aimed at: Academic leaders at research centres, TTO & KTO Directors
 

Impact

World Intellectual Property Indicators 2020

The World Intellectual Property Indicators 2020 report covers 2019 data, predating the human and economic shock of the COVID-19 pandemic. What this year’s WIPI documents, however, is a strong foundation of IP activity that will serve as a base for new advancements as the pandemic subsides.

  • Aimed at: Academic leaders at research centres, TTO & KTO Directors
 

Impact

Tea with ASTP: Corporate Partnerships

Ben Soffer, Head of Corporate Partnerships Kings College London presents ouon Corporate Partnerships.The MedTech Accelerator will act as a vehicle for the commercialisation of MedTech innovations. The Accelerator will be set up as a limited company based on a shareholder agreement and, in parallel, the parties are looking to facilitate the creation of a venture fund. The Accelerator has the ambition to position itself as the best place in the UK for MedTech Innovation to flourish successfully.

  • Aimed at: Academic leaders at research centres, TTO & KTO Directors